SLE (SYSTEMIC LUPUS)
Clinical trials for SLE (SYSTEMIC LUPUS) explained in plain language.
Never miss a new study
Get alerted when new SLE (SYSTEMIC LUPUS) trials appear
Sign up with your email to follow new studies for SLE (SYSTEMIC LUPUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug NTR-1011 tested for safety in lupus and arthritis patients
Disease control CompletedThis early-stage study tested the safety of a new drug called NTR-1011 in 36 healthy adults and people with lupus or rheumatoid arthritis. The goal was to find a safe dose and see how the drug works in the body. It was a randomized, double-blind, placebo-controlled trial, meaning…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: Neutrolis • Aim: Disease control
Last updated May 26, 2026 07:07 UTC
-
Engineered immune cells take on tough lupus cases
Disease control CompletedThis early-phase trial tested a new treatment for people with severe lupus that did not get better with standard medicines. The treatment uses a patient's own immune cells, modified in a lab to target and attack faulty immune cells causing the disease. Only 3 people took part, an…
Matched conditions: SLE (SYSTEMIC LUPUS)
Phase: PHASE1 • Sponsor: Chulalongkorn University • Aim: Disease control
Last updated May 22, 2026 13:50 UTC